US20050106598A1 - Novel peptide-conjugated oligomeric compounds - Google Patents

Novel peptide-conjugated oligomeric compounds Download PDF

Info

Publication number
US20050106598A1
US20050106598A1 US10/930,313 US93031304A US2005106598A1 US 20050106598 A1 US20050106598 A1 US 20050106598A1 US 93031304 A US93031304 A US 93031304A US 2005106598 A1 US2005106598 A1 US 2005106598A1
Authority
US
United States
Prior art keywords
seq id
oligomeric compound
acid
nucleic acid
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/930,313
Inventor
Muthiah Manoharan
Martin Maier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ionis Pharmaceuticals Inc
Original Assignee
Ionis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US10/222,595 priority Critical patent/US6878805B2/en
Application filed by Ionis Pharmaceuticals Inc filed Critical Ionis Pharmaceuticals Inc
Priority to US10/930,313 priority patent/US20050106598A1/en
Assigned to ISIS PHARMACEUTICALS, INC. reassignment ISIS PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MAIER, MARTIN E., MANOHARAN, MUTHIAH
Assigned to ISIS PHARMACEUTICALS, INC. reassignment ISIS PHARMACEUTICALS, INC. CORRECT TYPOGRAPHICAL ERROR IN INVENTOR'S NAME. CORRECT SPELLING IS MARTIN A. MAIER RECORDED AT REEL/FRAME 015570/0959 Assignors: MAIER, MARTIN A., MANOHARAN, MUTHIAH
Publication of US20050106598A1 publication Critical patent/US20050106598A1/en
Application status is Abandoned legal-status Critical

Links